Snowflake director Slootman sells 300,000 shares
The sales were made under a Rule 10b5-1 trading plan adopted September 19, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Snowflake Inc. director Frank Slootman exercised 300,000 fully vested stock options on October 19, 2026, at an $8.88 exercise price, acquiring 300,000 common shares and then selling 300,000 shares in ten reported transactions. The reported weighted-average sale prices ranged from $311.060 to $319.995 per share; the sales were made under a Rule 10b5-1 plan adopted September 19, 2025. The reported post-transaction stock-option position was 3,836,655 options.
Insider Trade Summary 10b5-1
Exercise and Sale: 300,000 shares ($92.27M approx. pre-tax spread)
Exercise and Sale
17 txns
Insider
Slootman Frank
Role
Director
Sold
300,000 shs ($94.93M)
Approx. gross sale proceeds
$94.93M
Approx. exercise cost
$2.66M
Approx. pre-tax spread
$92.27M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F18 | 300,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 300,000 | $8.88 | $2.66M |
| Sale | Common Stock F1, F3, F2 | 9,220 | $311.06 | $2.87M |
| Sale | Common Stock F1, F4, F2 | 11,959 | $312.401 | $3.74M |
| Sale | Common Stock F1, F5, F2 | 4,250 | $312.856 | $1.33M |
| Sale | Common Stock F1, F6, F2 | 22,761 | $314.458 | $7.16M |
| Sale | Common Stock F1, F7, F2 | 40,896 | $315.34 | $12.90M |
| Sale | Common Stock F1, F8, F2 | 68,376 | $316.324 | $21.63M |
| Sale | Common Stock F1, F9, F2 | 82,420 | $317.36 | $26.16M |
| Sale | Common Stock F1, F10, F2 | 39,298 | $318.258 | $12.51M |
| Sale | Common Stock F1, F11, F2 | 14,510 | $319.172 | $4.63M |
| Sale | Common Stock F1, F12, F2 | 6,310 | $319.995 | $2.02M |
| holding | Common Stock F13 | -- | -- | -- |
| holding | Common Stock F14 | -- | -- | -- |
| holding | Common Stock F15 | -- | -- | -- |
| holding | Common Stock F16 | -- | -- | -- |
| holding | Common Stock F17 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,836,655 contracts (Direct);
Common Stock — 19,024 shares (Direct);
Common Stock — 210,029 shares (Indirect, Trust)
Footnotes (18)
- F1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
- F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $310.705 to $311.695, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $311.725 to $312.690, inclusive.
- F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $312.745 to $313.680, inclusive.
- F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $313.755 to $314.750, inclusive.
- F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $314.760 to $315.750, inclusive.
- F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $315.760 to $316.755, inclusive.
- F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $316.760 to $317.750, inclusive.
- F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $317.760 to $318.745, inclusive.
- F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $318.830 to $319.820, inclusive.
- F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $319.860 to $320.270, inclusive.
- F13. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
- F14. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
- F15. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
- F16. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
- F17. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
- F18. The stock option is fully vested.
Key Figures
Stock options exercised: 300,000 options
Exercise price: $8.88 per share
Common shares acquired upon exercise: 300,000 shares
+3 more
6 metrics
Stock options exercised
300,000 options
October 19, 2026
Exercise price
$8.88 per share
Stock option exercise
Common shares acquired upon exercise
300,000 shares
October 19, 2026
Common shares sold
300,000 shares
Ten reported transactions on October 19, 2026
Weighted-average sale prices
$311.060–$319.995 per share
Reported sale transactions on October 19, 2026
Stock options after transaction
3,836,655 options
Reported post-transaction position
Key Terms
10b5-1 trading plan, weighted-average price, fully vested, restricted stock units
4 terms
10b5-1 trading plan regulatory
"sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
fully vested financial
"The stock option is fully vested."
restricted stock units financial
"vesting of one or more restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does the SNOW stock option Frank Slootman exercised expire?
The fully vested stock option reported in connection with the October 19, 2026 exercise has an expiration date of May 28, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
